Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy

BACKGROUND: Paraneoplastic hyperleucocytosis (PH) is sporadically seen in patients with advanced solid tumors. CASE PRESENTATION: We report a female patient with disseminated melanoma metastases. Two days after the first dosage of combined immunotherapy using the cytotoxic T lymphocyte antigen-4 (CT...

Descripción completa

Detalles Bibliográficos
Autores principales: Gambichler, Thilo, Stockfleth, E., Susok, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208032/
https://www.ncbi.nlm.nih.gov/pubmed/30376886
http://dx.doi.org/10.1186/s40425-018-0430-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208032/
https://www.ncbi.nlm.nih.gov/pubmed/30376886
http://dx.doi.org/10.1186/s40425-018-0430-y

Ejemplares similares